Latest Redmile Group, LLC Stock Portfolio
$2.72Billion– No. of Holdings #77
Redmile Group, LLC Performance:
2024 Q1: 11.92%YTD: 11.92%2023: 11.51%
Performance for 2024 Q1 is 11.92%, and YTD is 11.92%, and 2023 is 11.51%.
About Redmile Group, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Redmile Group, LLC reported an equity portfolio of $2.7 Billions as of 31 Mar, 2024.
The top stock holdings of Redmile Group, LLC are KRYS, FOLD, IMNM. The fund has invested 9.8% of it's portfolio in KRYSTAL BIOTECH INC and 5.7% of portfolio in AMICUS THERAPEUTICS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), RAYZEBIO INC and SPDR S&P 500 ETF TR (SPY) stocks. They significantly reduced their stock positions in CABALETTA BIO INC (CABA), PENUMBRA INC (PEN) and INTUITIVE SURGICAL INC (ISRG). Redmile Group, LLC opened new stock positions in SILENCE THERAPEUTICS PLC (SLN), 4D MOLECULAR THERAPEUTICS IN (FDMT) and KEROS THERAPEUTICS INC (KROS). The fund showed a lot of confidence in some stocks as they added substantially to VENTYX BIOSCIENCES INC (VTYX), STOKE THERAPEUTICS INC (STOK) and RAPT THERAPEUTICS INC (RAPT).
The top stock holdings of Redmile Group, LLC are KRYS, FOLD, IMNM. The fund has invested 9.8% of it's portfolio in KRYSTAL BIOTECH INC and 5.7% of portfolio in AMICUS THERAPEUTICS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), RAYZEBIO INC and SPDR S&P 500 ETF TR (SPY) stocks. They significantly reduced their stock positions in CABALETTA BIO INC (CABA), PENUMBRA INC (PEN) and INTUITIVE SURGICAL INC (ISRG). Redmile Group, LLC opened new stock positions in SILENCE THERAPEUTICS PLC (SLN), 4D MOLECULAR THERAPEUTICS IN (FDMT) and KEROS THERAPEUTICS INC (KROS). The fund showed a lot of confidence in some stocks as they added substantially to VENTYX BIOSCIENCES INC (VTYX), STOKE THERAPEUTICS INC (STOK) and RAPT THERAPEUTICS INC (RAPT).
Redmile Group, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024
Redmile Group, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Redmile Group, LLC made a return of 11.92% in the last quarter. In trailing 12 months, it's portfolio return was 36.4%.
New Buys
| Ticker | $ Bought |
|---|---|
| silence therapeutics plc | 43,797,600 |
| 4d molecular therapeutics in | 40,189,100 |
| keros therapeutics inc | 36,575,900 |
| the cigna group | 23,765,300 |
| ardelyx inc | 16,020,300 |
| boundless bio inc | 15,875,000 |
| icon plc | 12,413,000 |
| progyny inc | 12,241,000 |
New stocks bought by Redmile Group, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ventyx biosciences inc | 944 |
| stoke therapeutics inc | 93.22 |
| rapt therapeutics inc | 80.6 |
| align technology inc | 74.22 |
| akero therapeutics inc | 67.53 |
| prime medicine inc | 56.63 |
| nurix therapeutics inc | 37.66 |
| cogent biosciences inc | 35.98 |
Additions to existing portfolio by Redmile Group, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| cabaletta bio inc | -67.78 |
| penumbra inc | -53.16 |
| intuitive surgical inc | -45.55 |
| catalent inc | -42.53 |
| hca healthcare inc | -20.59 |
| biohaven ltd | -19.46 |
| boston scientific corp | -19.08 |
| evolent health inc | -18.71 |
Redmile Group, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| immunogen inc | -486,969,000 |
| rayzebio inc | -115,494,000 |
| invitae corp | -923,919 |
| science 37 holdings inc | -5,288,800 |
| medavail holdings inc | -3,052,080 |
| atreca inc | -58,430 |
| somalogic inc | -938,223 |
| spdr s&p 500 etf tr | -67,731,700 |
Redmile Group, LLC got rid off the above stocks
Sector Distribution
Redmile Group, LLC has about 87.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.3 |
| Others | 12.5 |
Market Cap. Distribution
Redmile Group, LLC has about 7.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 46.2 |
| MID-CAP | 29.3 |
| UNALLOCATED | 12.5 |
| LARGE-CAP | 7.5 |
| NANO-CAP | 2.5 |
| MICRO-CAP | 2.1 |
Stocks belong to which Index?
About 76.9% of the stocks held by Redmile Group, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 68.1 |
| Others | 23.1 |
| S&P 500 | 8.8 |
Redmile Group, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Redmile Group, LLC
Redmile Group, LLC has 77 stocks in it's portfolio. About 41.9% of the portfolio is in top 10 stocks. FOLD proved to be the most loss making stock for the portfolio. KRYS was the most profitable stock for Redmile Group, LLC last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 1.72 | 8,253,320 | 46,878,800 | added | 2.77 | ||
| ABT | abbott labs | 1.09 | 262,371 | 29,821,100 | reduced | -1.18 | ||
| ACHL | achilles therapeutics plc | 0.07 | 1,608,090 | 2,010,110 | unchanged | 0.00 | ||
| ACIU | ac immune sa | 0.22 | 2,007,030 | 5,940,810 | added | 0.35 | ||
| ADAP | adaptimmune therapeutics plc | 0.04 | 715,607 | 1,130,660 | unchanged | 0.00 | ||
| ADCT | adc therapeutics sa | 2.52 | 15,269,200 | 68,558,800 | reduced | -0.39 | ||
| ADGI | invivyd inc | 0.23 | 1,440,720 | 6,396,820 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 1.72 | 1,858,700 | 46,950,800 | added | 67.53 | ||
| ALGN | align technology inc | 1.05 | 87,255 | 28,612,700 | added | 74.22 | ||
| ALLK | allakos inc | 0.16 | 3,451,080 | 4,348,360 | reduced | -5.98 | ||
| ALVR | allovir inc | 0.05 | 1,907,970 | 1,440,330 | unchanged | 0.00 | ||
| ALXO | alx oncology hldgs inc | 1.77 | 4,326,510 | 48,240,600 | added | 18.23 | ||
| ANNX | annexon inc | 1.45 | 5,503,190 | 39,457,900 | unchanged | 0.00 | ||
| APLS | apellis pharmaceuticals inc | 0.33 | 155,000 | 9,110,900 | new | |||
| ARDX | ardelyx inc | 0.59 | 2,194,560 | 16,020,300 | new | |||
| ATRA | atara biotherapeutics inc | 0.24 | 9,263,310 | 6,428,740 | added | 1.72 | ||
| AUGX | augmedix inc | 2.46 | 16,380,300 | 66,995,500 | unchanged | 0.00 | ||
| BCEL | atreca inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BEAM | beam therapeutics inc | 2.28 | 1,879,620 | 62,102,500 | added | 31.46 | ||
| BPMC | blueprint medicines corp | 0.39 | 113,060 | 10,724,900 | new | |||